Julujak Limsrivilai

21PUBLICATIONS
84CO-AUTHORS
Gene and molecular therapyCentral and Eastern European languages (incl. Russian)Clinical pharmacology and therapeuticsElectrostatics and electrodynamicsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Oct 25, 2026
Prevalence and impact of Thiopurine S-methyltransferase (TPMT) and Nudix hydrolase 15 (NUDT15) polymorphisms on the occurrence of myelosuppression in Thai patients with inflammatory bowel disease receiving thiopurine therapy.

|May 20, 2026
Inflammatory bowel disease phenotypes in diverse populations: a global comparative analysis.

|May 12, 2026
Asian Pacific Association of Gastroenterology (APAGE) Clinical Practice Guidelines on the Use of Small Molecules and IL-23 p19 Inhibitors in Ulcerative Colitis and Crohn's Disease.

|Feb 20, 2026
Clinical characteristics of isolated perianal Crohn's disease and validation of the TOpClass criteria: a retrospective cohort pilot study.

Wasuwit Wanchaitanawong, Varut Lohsiriwat, Sitthipong Srisajjakul

|Feb 13, 2026
Cost-Consequences Analysis of Biologic Treatments for Moderate-to-Severe Crohn's Disease Using Real-World Transition Probability and Cost Data in Thailand.

Thanaboon Chaemsupaphan, Onuma Sattayalertyanyong, Khachen Kongpakwattana

|Jul 23, 2025
Increased Fiber Intake Enhances Clostridia Bacteria and Reduces Clinical Relapse in Patients With Clinically Quiescent Inflammatory Bowel Disease: A Prospective Longitudinal Study.

Julajak Limsrivilai, Phalat Sathirawich, Onuma Sattayalertyanyong

Pageof 4

Frequent Collaborators

5 joint publications

Siew-Chien Ng

4 joint publications

Yan Chen

2 joint publications

Jesus K Yamamoto-Furusho

2 joint publications

Angela J Forbes